Mauna Kea Technologies

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

News - Cellvizio - Jul 20, 2020

Mauna Kea Technologies reports second quarter and first half of 2020 sales

First Half of 2020 total sales down 47%; U.S. sales down 19%
Second Quarter total sales down 72%; U.S. sales down 47%
Sufficient liquidity to manage the business through the third quarter of 2021

READ THE COMPLETE PRESS RELEASE

You might also like to read

News & Events Card Image (3).png

NEWS - Cellvizio

Mauna Kea Technologies Announces the Launch of a First in Human Study Combining Robotic Navigational Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy

News & Events Card Image (3).png

NEWS - Cellvizio

Cellvizio® Endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as a Safe and Effective Diagnostic Tool

News & Events Card Image (3).png

NEWS - Cellvizio

Mauna Kea Technologies Receives FDA Clearance and CE Marking For Its Next-Generation Cellvizio® Platform